Groowe Groowe BETA / Newsroom
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

Global Therapeutic Drug Monitoring Market to 2033: Precision Medicine and Personalized Dosing Drive Growth Opportunities Amid Rising Competition

globenewswire.com
ABT Abbott Laboratories is listed as a prominent participant in the competitive global therapeutic drug monitoring market, which is projected for sustained growth. The article does not provide specific sentiment towards Abbott. TMO Thermo Fisher Scientific is identified as a prominent participant in the growing therapeutic drug monitoring market. The article does not offer specific sentiment or details about their performance. BIO Bio-Rad Laboratories is named as a prominent participant in the competitive therapeutic drug monitoring market. The article does not offer specific sentiment or details about their role or performance.

Global Therapeutic Drug Monitoring Market to 2033: Precision Medicine and Personalized Dosing Drive Growth Opportunities Amid Rising Competition Dublin, Sept. 22, 2026 (GLOBE NEWSWIRE) -- "Therapeutic Drug Monitoring Market Insights, Competitive Landscape, and Market Forecast - 2033" has been added to ResearchAndMarkets.com's offering.

The global therapeutic drug monitoring (TDM) market is projected to expand from USD 2.8 billion in 2026 to USD 5.2 billion by 2033, representing a compound annual growth rate (CAGR) of 9.5% during the forecast period. Market growth is being supported by the increasing prevalence of chronic diseases, wider adoption of personalized medicine, heightened focus on drug safety, and continued advances in clinical diagnostic technologies.

Healthcare providers are increasingly using therapeutic drug monitoring to support precision dosing, improve treatment efficacy, and reduce the risk of adverse drug reactions. Demand is particularly strong for patients receiving antiepileptic drugs, antibiotics, immunosuppressants, antiarrhythmics, bronchodilators, and psychoactive medications. The growing clinical emphasis on individualized treatment regimens is expected to strengthen the role of TDM across hospitals, commercial laboratories, and private diagnostic facilities.

Therapeutic Drug Monitoring Market Trends

Technology innovation remains a central driver of global market expansion. Immunoassay analyzers, clinical chemistry systems, chromatography-mass spectrometry platforms, and advanced consumables are improving the accuracy, reliability, and speed of drug concentration testing. Chemiluminescence immunoassays, fluorescence immunoassays, liquid chromatography-mass spectrometry (LC-MS), and gas chromatography-mass spectrometry (GC-MS) are also enabling laboratories to address increasingly complex testing requirements.

Automated TDM platforms are helping hospital laboratories streamline workflows, reduce turnaround times, and improve testing consistency. At the same time, the integration of artificial intelligence and advanced data analytics may enhance dosage prediction, support clinical decision-making, and help reduce medication-related complications. Companies that successfully combine laboratory automation, analytical precision, and clinical data management are expected to gain a competitive advantage.

Key Market Growth Drivers

Business Opportunities

Emerging economies offer substantial opportunities for therapeutic drug monitoring companies as healthcare infrastructure improves and awareness of personalized treatment increases. Affordable, rapid, and scalable diagnostic solutions could support wider adoption in resource-constrained regions. Strategic partnerships between diagnostic manufacturers, healthcare systems, hospital networks, and reference laboratories may further accelerate market penetration.

Research and development investment will remain critical to the introduction of next-generation analyzers, high-performance assays, and integrated laboratory platforms. Additional opportunities are expected in artificial intelligence-enabled dosage optimization, automated interpretation, data connectivity, and clinical decision-support systems.

Regional Market Outlook

Competitive Landscape

The global therapeutic drug monitoring market remains highly competitive. Prominent participants include Abbott Laboratories, Roche Diagnostics, Siemens Healthineers, Thermo Fisher Scientific, Beckman Coulter, bioMerieux, QuidelOrtho, Agilent Technologies, PerkinElmer, Bio-Rad Laboratories, Sysmex Corporation, Werfen, Tosoh Corporation, and Eurofins Scientific. Leading companies are prioritizing product innovation, strategic collaborations, laboratory automation, and expansion into high-growth markets.

Market Segmentation

By product type, the market includes consumables, equipment, immunoassay analyzers, chromatography and mass spectrometry detectors, and clinical chemistry analyzers. Technology segments include immunoassays, chemiluminescence immunoassays, colorimetric immunoassays, fluorescence immunoassays, radioimmunoassays, chromatography-MS, LC-MS, and GC-MS.

Drug-class segmentation covers antiepileptic drugs, antibiotics, immunosuppressants, antiarrhythmics, bronchodilators, psychoactive drugs, and other medications. Primary end users include hospital laboratories and commercial or private laboratories. Geographically, the market is evaluated across North America, Europe, Asia-Pacific, Latin America, the Middle East, and Africa.

With precision medicine gaining momentum and healthcare organizations placing greater emphasis on treatment safety and efficacy, the therapeutic drug monitoring market is positioned for sustained global growth through 2033.

Companies Featured

For more information about this report visit https://www.researchandmarkets.com/r/6bo3hm

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.